TY - JOUR T1 - Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI) JF - bioRxiv DO - 10.1101/2020.01.14.905539 SP - 2020.01.14.905539 AU - Thivanka Muthumalage AU - Michelle R. Friedman AU - Matthew D. McGraw AU - Alan E. Friedman AU - Irfan Rahman Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/01/15/2020.01.14.905539.abstract N2 - Background The Centers for Disease Control (CDC) declared e-cigarette (e-cig), or vaping product use-associated lung injury (EVALI) a national outbreak due to the high incidence of emergency department admissions and deaths. Investigators have identified vitamin E acetate (VEA) as the plausible cause for EVALI, based on compounds found in bronchoalveolar lavage fluid.Objectives We defined the chemical constituents present in e-cig cartridges associated with EVALI and compared constituents to medical-grade and cannabidiol (CBD) containing cartridges.Methods We measured chemicals and elemental metals in e-liquid and vapor phases of e-cig counterfeit cartridges by Gas Chromatography (GC) and Mass Spectrometry (MS), EPA method TO-15 by GCMS, and ICP-MS analysis.Results We have identified chemical constituents in e-cig vaping tetrahydrocannabinol (THC)-containing counterfeit cartridges compared to medical-grade and cannabidiol (CBD) containing cartridges. Apart from VEA and THC, other potential toxicants correlated with EVALI included solvent-derived hydrocarbons, silicon conjugated compounds, various terpenes, pesticides/plasticizers/polycaprolactones, and metals. These chemicals are known to cause symptoms, such as cough, shortness of breath or chest pain, nausea, vomiting or diarrhea, fatigue, fever, or weight loss, all symptoms presenting in patients with EVALI.Conclusion This study provides insights into understanding the chemical-induced disease mechanism of acute lung injury. ER -